AlphaCentric Advisors’s CytomX Therapeutics CTMX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-257,500	Closed	-$373K	–	176
2022 Q3	$373K	Buy	+257,500	New	+$373K	0.38%	69